rat (9) and in vascular smooth muscle cells isolated from the rat aorta (10) . Saed (11) has demonstrated the presence of tissue kallikrein mRNA in rat arteries and veins and in isolated smooth muscle cells of the rat. Kallikrein-like activity is present in human tissue from aorta and renal arteries (12) . Moshi and co-workers described a kininogenase in canine myocardium and aorta, which releases bradykinin and shows similarities with tissue kallikrein (13) . However, most investigators attribute tissue kallikrein activity to the vascular smooth muscle cells, but not to endothelial cells, although the vascular endothelium seems to be one of the main targets of kinin action (l -4). Therefore we investigated the presence of tissue kallikrein in cultured human endothelial cells by three different methods: immunostaining, measurement of enzyme activity, and measurement of kinin release.
Materials and Methods

Cell culture
Human umbilical vein endothelial cells were prepared according to the method of Jaffe (14) s previously described (15) . For the preparation of human pulmonary artery endothelial cells, Segments of human pulmonary arteries (1.5-3.5 cm ? ) were incubated in 2 g/l collagenase (Roth, Karlsruhe, Germany) for 30 minutes at 37 °C. The segments were then rinsed with Medium 199 containing fetal calf serum, volume fraction 0.2 (Gibco-BRL, Berlin, Germany), and the detached cells were collected. The cell Suspension was pelleted and seeded into a 35 mm dish (Falcon, Heidelberg, Germany) coated with 2 g/l gelatine (Sigma, Deisenhofen, Germany) and incubated in culture medium at 37 °C and 5% CO2-The culture conditions for endothelial cells from human umbilical veins and endothelial cells from human pulmonary arteries were similar. The culture medium contained Medium 199, fetal calf serum (volume fraction 0.2), l O 5 U/l penicillin, 100 mg/1 streptomycin, 10 mmol/1 HEPES (all Sigma), 0.2 mol/11-glutamine (Seromed, Berlin, Germ any), and 10 μg/l endothelial cell growth factor (Boehringer, Mannheim, Germany). All experiments were performed with cells of the second passage. The purity and identity of the endothelial cultures was determined by measuring factor VIII related antigen, using a specific antibody (Dako, Hamburg, Germany), and by measuring the uptake of fluorescence conjugated-low density lipop rotein in confluent monolayers (Paesel & Lorei, Mainz, Germany) (16) . Endothelial cells were counted using a haemocytometer.
phosphoramidon (10 nmol/1) and lisinopril .(ΓμηΐοΙ/1, ICI, Germany). Confluent monolayers were washed twice with phosphateb uffered saline, incubation medium was added, and the cells were incubated at 37 °C. After 10 minutes, l hour and 4 hours, aliquots of 0.2 ml were taken, frozen in liquid nitrogen, and stored at -70 °C until measurement of kinin concentrations by RIA.
• r Kinin release in endothelial cell hornogenates All experiments were done in 2 ml incubation medium. Confluent monolayers were washed twice with phosphate-buffered saline. Thereafter, the incubation medium was added and the cultures were allowed to equilibrate for 15 minutes. The eells were then scraped off the culture dish and homogeriised by sonication s described above. Aliquots of 0.2 ml were taken immediately aftef hpmogenisation and after 5 and 30 minutes. Aliquots were mixed with 0.2 ml Tris-buffer (0.2 mol/1 Tris, 0.01 mol/1 EDTA, pH 7.4, Serva AG, Heidelberg, Germany) on ice, frozen in liquid nitrogen, and stored at -^70 °C. Parallel experiments were performed in the presence of 1000 klU/dish aprotinin (Bayer AG, Leverkusen, Germany), which was added 15 minutes prior to homogenisation. In a second set of experiments, confluent cell monolayers were washed twice with dextran sulphate (100 mg/1, Sigma) for 4 minutes at room temperature. Then the cells were incubated with the incubation medium and bradykinin release was measured s described above. To some cell homogenates, 0.5 or 5 U/l porcine tissue kallikrein (Sigma) was added, and aliquots for kinin determination were taken at 5, 30 and 60 minutes afterwards.
Immunostaining
Endothelial cells were placed in phosphate-buffered saline containing 10 g/l bovine serum. albumin (Sigma). Cytocentrifugal specim ens containing 2 X l O 5 endothelial cells per slide were prepared \ using a Cytospin 2 (Shandon Southern Prod. Ltd., Runcorn, °C heshire, UK) at 150 g for 5 minutes. All cytocentrifuge s des were stained by the alkaline phosphatase anti-alkaline phosphatase method described by Cordeil (17) . The fixed cells were stained with an anti-human tissue kallikrein antiserum (dilutiori l: 1000) (18) or an antibody against factor VIII related antigen (dilution l : 100, Dako), which was used s positive control. Incubation with a preimmune antiserum (instead of kallikrein antibody) was perf ormed s a negative control. After immunostaining, slides were counterstained with Mayer's acid haematoxylin. The number of positive cells was estimated by evaluation of 5 mieroscopic powerflelds of each specimen (magnification X 200; endothelial cells from human umbilical Veins: n = 5, endothelial cells from human pulmonary arteries: n = 3).
Measurement of tissue kallikrein activity in endothelial cells
Confluent monolayers of endothelial cells from human umbilical veins and endothelial cells from human pulmonary arteries in 35 mm dishes were washed twice with phosphate-buffered saline (Gibco-BRL), scraped off the dish with a rubber policeman, suspended in 0.5 ml Tris buffer (0.1 mol/1, pH 7.4), containing l ml/l Tween 20 (Serva, Heidelberg, Germany), then sonicated for 5 seconds (20% Output energy) with a Sonifier B-12 (Branson Sonic Power Co., Danbury, Co., USA) on ice. Samples of the cell homogenate were assayed immediately for tissue kallikrein activity.
Kinin release in endothelial cell supernatants
All experiments were done in 1.5 ml serum-free incubation medium to avoid interference of the serum with the bradykinin RIA. 8 The serum-free medium contained RPMI 1640 (Gibco-BRL), 10 mmol/1 HEPES (Sigma), antibiotics and the peptidase Inhibitors, Assay for tissue kallikrein activity Tissue kallikrein activity was assessed by the colorimetric measurement of the release of 4-nitroaniline (l 9). Twenty iiiicn> Ihres of Standard (0.1, 0.25, 0.5, l, 2, 4, 8 mU porcine tissue kallikrein, Sigma) or sample were diluted in a total volume of 150 μΐ (0.1 mol/1 Tris, 0.234 mol/l NaCl, pH 7.8). Assays were performed using 96-well titre plates (Falcon, Heidelberg, Germany). The enzymatic reaction was started by addition of 150 μΐ of 0:5 mmol/1 D-Val-cyclohexyl-Ala-Arg-4-nitraniline (Chromozym GK, Boehringer, Germany) in ie presence and absence.of 200 klU aprotinin (Bayer AG). The absorbance at 405 nm (Titertek MCC 340; Lausanne, Switzerland) was measured to determine the 4-nitroaniline felease after l, 2, 3, and 6 hours. Tissue kallikrein activity was calculated from the maximal slope of 4-nitroaniline generation. One mU porcine tissue kallikrein (Sigma) indueed an increase of ΔΑ4 0 5ηιη/10 min = 0.052 ± 0.005 (n = 12). Orily the activity of the reaction inhibited by aprotinin was attributed to tissue kalll· krein-like activity. »i
Kinin radioimmunoassay
Immunoreactive kinins were measured by a radioimmunoassay (RIA) described previously (15, 20 
Results
Immunostaining of tissue kallikrein
The presence of tissue kallikrein immunoreactivity was demonstrated by immunostaining. The endothelial cells from umbilical veins labelled with the anti-human käl-likrein antibody appeared red; between 55 and 78% of cells showed a positive staining (n = 5, fig. 1 ). The staining of endothelial cells from human pulmonary arteries demonstrated tissue kallikrein immunoreactivity in 65-75% of the cells (n = 3). Control staining with sefum instead of the specific antibody resulted in no specific phosphatase reactioris. Between 85 and 95% of cells (n = 3) gave a positive staining reaction with factor Vill related antigeri. 
Enzymatic activity of tissue kallikrein in endothelial cells
Kallikrein enzyme activity in cell homogenates of endothelial cells from human umbilical veins was detected by the cleavage of D-Val-cyclohexyl-Ala-Arg-4-nitraniline. The total activity was determined äs 5.0 ± 1.1 mU/10 6 cells (n = 8), the activity inhibited by aprotinin, attributed to tissue kallikrein-like activity, was 3.57 ± 0.47 mU/10 6 cells in endothelial cells from human umbilical veins. In endothelial cells from human pulmonary arteries the total activity was 11.2 ± 1.2 mU/10 6 cells, and the tissue kallikrein-like activity was 7.52 ± 0.82 mU/ l O 6 cells (n = 4, p < 0.01 vs. endothelial cells from human umbilical veins).
Kinin release into supernatants
In the presence of the angiotensin converting enzymeinhibitor, lisinopril, and the neutral endopeptidase 24.11-inhibitor, phosphoramidon, the following kinin-concentrations were measured: 10 minutes 40 ± 18 ng/1, l hour 52 ± 23 ng/1, 4 hours 35 ± 15 ng/1 (n = 9 at each time point). No immunoreactive kinins were detected in the incubation medium alone, or in supernatants without the peptidase inhibitors, at all time points (n = 6).
Kinin release in endothelial cells from human umbilical veins
No immunoreactive kinins were detected after homogenisation of cells in the absence of the peptidase inhibitors, lisinopril and phosphoramidon. In the presence of both inhibitors, kinin contents of 424 ± 83 pg/10 6 cells (n = 8) were measured directly after homogenisation. After 5 minutes, the kinin concentration increased further to 627 ± 57 pg/10 6 cells (n = 8) and remained nearly unchanged during 30 minutes. The presence of the tissue kallikrein inhibitor, aprotinin (1000 klU/dish), resulted in significantly lower concentrations at all time points (P < 0.05 vs. control). Treatment of the cells with 100 mg/1 dextran sulphate reduced the cellular kinin content from 424 ± 83 pg/10 6 cells to 102 ± 14 pg/10 Addition of 5 mU tissue kallikrein immediately after homogenisation resulted in a fivefold increase during the first 5 minutes up to 2575 ± 400 pg/10 6 cells (n = 6, p < 0.01), which declined during the following 25 minutes ( fig. 3) . 
Kinin release in endothelial cells from human pulmonary arteries
Similar experiments were performed with endothelial cells derived from the human pulmonary artery. In homogenates of endothelial cells from human pulmonary arteries, no immunoreactive kinins were detected without the peptidase inhibitors. In the presence of lisinopril and phosphoramidon, kinin Contents of 576 ± 146 pg/10 6 cells (n = 4) were detected immediately after homogenisation. After 5 and 30 minutes, the kinin concentration significantly increased to 857 ± 106 pg/10 fig. 2b ),
Discüssion
The present data provide immunohistologicäl and func-= tiqnal evidence for the presence of tissue kallikrein in cultured endothelial cells from human umbilical veins and pulmonary arteries. About two thirds of the endothelial cells from umbilical veins and pulmonary arteries showed positive staining after immunostaining with a highly specific antiserum against tissue kallikreiii (18) . The control staining with the endothelial marker (factor VIII related antigeii) was positive in nearly all the cells. This confirmed that the tissue kallikrem-immunoreactivity can be attributed to human endothelial cells. The tissue kallikrein antigen was not found in all the cells, possibly because low quantities of kallikrein are present, or the staining technique has low sensitivity. We observed a similar pattern of positive and negative cells in human smooth musele cells (21) . As reported pfeviously by various authors (9-13), tissue kallikrein is present in vascular smooth musele cells. Therefore, the apparent abserice of immunoreactivity in some endothelial cells may be due to a methodological problem. In all experiments the majority of the endothelial cells were positive for tissue-kallikrein immunoreactivity.
Tissue kallikrein-like activity was measured by a well characterised colorirnetric assay (19) . Since the specificity of chromogenic Substrates is not very high, we performed parallel measürements in the presence of the tissue kallikrein inhibitor, aprotinin, to exclude major unspecific protease activity, including plasma kallikrein. Aprotinin blocked more than 75% of the total enzymatic activity in endothelial cells. These results might indicate that the major kininogenase activity in endothelial cell can be attributed to a tissue kallikrein-like enzyme.
Kinins are generated by enzymatic cleavage of high molecular weight kininogen $nd low molecular weight kininogen by kallikreins. Both kininogens are synthesised in the liver and are found.iri plasma. High molecular rnass kininogen binding sites have been detected on cultured endothelial cells (22, 23) . A recently pub--lished study shows binding of high molecular mass kininogen to the eridotheliurri of human umbilical veins in situ and the generation of bndykinin from the receptori bound high molecular weight kininogen after addition of plasma kallikrein (24) . Therefore, it seems likely that high molecular weight kininogen is the major Substrate of the endothelial kinin generation. Van Iwaarden et al. (22) reported that treatment of endothelial cells with dextran sulphate completely removed the receptorbound high molecular weight kininogen. In our experiments, an approximately 75% reduction of kinin release in endothelial cells from human umbilical veins and endothelial cells from human pulmonary arteries occurred after washing with dextran sulphate. This indicates that the main source of kininogen is receptor-bound extracellular kininogen. Only the minor part of kininogen appears to be localized intracellularly. Whether intracellular kininogen is synthesised by endothelial cells or derives from serum or plasma is controversely discussed in various reports (22) (23) (24) . In our study the intracellular kinin concentrations measured immediately after homogenisation were within the ränge of concentrations causing physiological responses like vasodilatation (l, 2, 6) and were 8 to 10 fold higher than the kinin concentrations found in the supernatants. We measured a further increase of kinin generation in endothelial cells during the following 30 mimites after homogenisation. The increase of kinin generation during this time can be explained by further cleavage of kininogen by cellular proteases, including kallikreins. Parallel incubation with the protease inhibitor, aprotinin, an inhibitor of tissue kallikrein, reduced cellular kinin concentrations and abolished the increase of kinins in the homogenates during this time period, süggesting a role for tissue kallikrein in endothelial kinin formation.
Since human umbilical vein endothelial cells are often considered to be embryonic cells, which inight be different from adult phenotypes, we performed parallel experiments with adult endothelial cells derived from Segments of the pulmonary artery. We obtairied similar results for the measurement of tissue kallikrein-like activity and cellular kinin formation in endothelial cells from the pulmonary circulätion, which confirms the results of the experiments with endothelial cells from human umbilical veins. Pifferent amounts of kallikreinlike activity were measured in endothelial cells from human umbilical veins and endothelial cells from human pulmonäry arteries. It has been reported before that tissue-like kallikrein activity varies in homogenates from different human vessels (12) .
The present data demonstrate that certain requirements have to be met to measure kinin formation and release from endothelial cells. The most important condition is the Inhibition of bradykinin degrading enzymes. The most potent of these is angiotensin converting enzyme (2) . Another kininase II, the neutral endopeptidase 24.11, is also involved in the degradation of bradykinin (25) . Intra-and extracellular kinins were only detected when both enzymes had been blocked by inhibitors. The second requirement is the exogenous supply of kininogen (22, 24) , which is normally present in cell culture medium. Whether disintegration (like homogenisation) of the cells is a requirement for kinin release is not sure. However, we measured much higher concentrations of kinins in homogenates than in supernatants. Present data from different studies (6, 8, 25) indicate that physiological Stimuli like flow, shear stress or ischaemia might be a Stimulus for local kinin release.
A recent publication by Wang and colleagues provides evidence that tissue kallikrein is a powerfull modulator of blood pressure in vivo (26) . Transgenic mice carrying the human tissue kallikrein gene demonstrated hypotensive blood pressure, when tissue kallikrein was overexpressed in tissues and serum. Recent cloning of human tissue kallikrein gene and its transcripts from colon (27) might provide the basis for detailed investigation of tissue kallikrein expression in endothelial cells in the near future.
In the present study we demonstrated that tissue kallikrein is present in human endothelial cells derived from umbilical veins and pulmonary arteries, and that it contributes to local kinin formation in vitro.
